PeptidePedia The community reference

Talk:Deamidation

Discussion page·2 threads·no archives

This article is within the scope of the analytical working group.

This is the discussion page for the article Deamidation. It is for improving the article: sources, wording, structure, scope and titles. It is not a general discussion forum about the subject, and it is not a place to ask for advice — see Project:Medical disclaimer.

Isoaspartate is invisible to massResolved

Worth being explicit that isoaspartate is isobaric with aspartate, so even a high-resolution instrument sees only the +0.984 shift and not which product formed. — MassSpecMarv (talk) 10:05, 25 February 2026 (UTC)

Added. It is the reason a specific method is needed rather than better mass resolution. ✓ Done — AAA_Analyst (talk) 13:40, 25 February 2026 (UTC)

Resolved. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.

Storage versus manufactureDone

The sentence noting that a low purity figure on community-tested material may be characterising storage is the same point made at Chain of custody and it belongs in both places. — ChainCustodyChad (talk) 09:50, 30 April 2026 (UTC)

Deamidation is the mechanism that makes the point concrete, so it is more persuasive here than in the abstract. ✓ Done — StabilityStig (talk) 13:25, 30 April 2026 (UTC)

Done. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.
This page was last edited on 30 April 2026, by StabilityStig. Text is available under the PeptidePedia Wiki Content Licence (PPCL-BY-SA 4.0).